Pyrosequencing Q1 Revenues Surge | GenomeWeb

NEW YORK, May 2 – Pyrosequencing of Uppsala, Sweden said Wednesday its first quarter revenues jumped six-fold to $1.9 million, compared with $300,000 in the year-ago quarter.

The SNP company linked revenue increases to 17 new sales of their PSQ 96 System during the quarter, compared to five instruments in the same quarter in 2000. Additionally, Pyrosequencing reported a rise in an installed base of 80 systems for applied genetic analysis worldwide.

The company’s expenses rose to $5.1 million from $2.7 million for the first quarter of 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.